Zveme vás na další ze série SPARK Europe Webinar Series - 7. září od 16 hodin

What is the utility of observational data, and how does it differ from data collected under experimental conditions such as randomized controlled trials (RCTs)? Does it have any other value than optimizing market access in pharma companies? Late-stage clinical research data is not easy to collect and manage but can dramatically improve drug development and clarify the value of new therapies.

15. 8. 2022

Daniel is the Chief Information Officer (CIO) of IBA Ltd. and an associate professor at Masaryk University and the Brno University of Technology. Besides his research in neuroscience, medical image analysis, and machine learning, he also works on data security, data management, and data science in clinical research.

Marika is the Head of the Department of Clinical Projects at IBA Ltd. She has dealt with project management, quality management, and regulatory affairs in the pharmaceutical industry since 2003. In her career, she has led dozens of research projects focusing on medical devices and medicinal products: from basic research and pre-clinical and clinical development to a successful product on the market.

Online via MS Teams ǀ Please register here! Registration for the webinar is required in advance.

The webinar will be hosted by SPARK at the Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Více článků

Přehled všech článků

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info